WDNA vs. LFSC

Last updated Apr 1, 2026

Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and F/m Emerald Life Sciences Innovation ETF (LFSC).

WDNA and LFSC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024.

Performance

WDNA vs. LFSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and F/m Emerald Life Sciences Innovation ETF (LFSC). The values are adjusted to include any dividend payments, if applicable.

WDNA vs. LFSC - Yearly Performance Comparison

	2026 (YTD)	2025	2024
WDNA WisdomTree BioRevolution Fund	2.99%	22.68%	-7.07%
LFSC F/m Emerald Life Sciences Innovation ETF	-4.45%	56.54%	-6.02%

Returns By Period

In the year-to-date period, WDNA achieves a 2.99% return, which is significantly higher than LFSC's -4.45% return.

WDNA

• 1D: 4.08%
• 1M: -4.89%
• YTD: 2.99%
• 6M: 14.31%
• 1Y: 41.33%
• 3Y*: 2.41%
• 5Y*: —
• 10Y*: —

LFSC

• 1D: 6.16%
• 1M: -3.82%
• YTD: -4.45%
• 6M: 17.66%
• 1Y: 55.83%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. LFSC - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than LFSC's 0.54% expense ratio.

LFSC

F/m Emerald Life Sciences Innovation ETF

WDNA

WisdomTree BioRevolution Fund

Return for Risk

WDNA vs. LFSC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA

WDNA Risk / Return Rank: 78
WDNA Sharpe Ratio Rank: 77
WDNA Sortino Ratio Rank: 80
WDNA Omega Ratio Rank: 67
WDNA Calmar Ratio Rank: 91
WDNA Martin Ratio Rank: 73

LFSC

LFSC Risk / Return Rank: 86
LFSC Sharpe Ratio Rank: 89
LFSC Sortino Ratio Rank: 90
LFSC Omega Ratio Rank: 82
LFSC Calmar Ratio Rank: 91
LFSC Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. LFSC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WDNA	LFSC	Difference
Sharpe ratio Return per unit of total volatility	1.40	1.93	-0.52
Sortino ratio Return per unit of downside risk	2.06	2.65	-0.59
Omega ratio Gain probability vs. loss probability	1.25	1.33	-0.08
Calmar ratio Return relative to maximum drawdown	3.20	3.20	0.00
Martin ratio Return relative to average drawdown	7.58	8.96	-1.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WDNA vs. LFSC - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.40, which is comparable to the LFSC Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of WDNA and LFSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WDNA	LFSC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.40	1.93	-0.52
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	0.94	-1.18

Correlation

The correlation between WDNA and LFSC is 0.76, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

WDNA vs. LFSC - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.43%, while LFSC has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021
WDNA WisdomTree BioRevolution Fund	4.43%	4.57%	0.75%	0.80%	0.38%	0.10%
LFSC F/m Emerald Life Sciences Innovation ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

WDNA vs. LFSC - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than LFSC's maximum drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for WDNA and LFSC.

Drawdown Indicators

	WDNA	LFSC	Difference
Max Drawdown Largest peak-to-trough decline	-58.87%	-29.74%	-29.13%
Max Drawdown (1Y) Largest decline over 1 year	-11.70%	-16.25%	+4.55%
Current Drawdown Current decline from peak	-33.71%	-11.08%	-22.63%
Average Drawdown Average peak-to-trough decline	-35.79%	-8.25%	-27.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.20%	5.80%	-0.60%

Volatility

WDNA vs. LFSC - Volatility Comparison

The current volatility for WisdomTree BioRevolution Fund (WDNA) is 8.88%, while F/m Emerald Life Sciences Innovation ETF (LFSC) has a volatility of 10.35%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than LFSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WDNA	LFSC	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.88%	10.35%	-1.47%
Volatility (6M) Calculated over the trailing 6-month period	18.59%	19.97%	-1.38%
Volatility (1Y) Calculated over the trailing 1-year period	29.63%	29.24%	+0.39%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.17%	29.31%	-4.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.17%	29.31%	-4.14%